4369 Tri Chemical Laboratories Inc. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

4369

TSE Prime

Tri Chemical Laboratories Inc.

3,090

JPY

+70

(+2.32%)

Dec 5, 2:14 pm JST

19.95

USD

Dec 5, 12:14 am EST

Result

PTS

outside of trading hours

3,094.5

Dec 5, 2:12 pm JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jan, 2022	11,574	2,976	5,294	4,095	126.3	20	Mar 15, 2022	J-GAAP
Jan, 2023	13,803	3,504	6,186	4,832	148.7	30	Mar 15, 2023	J-GAAP
Jan, 2024	11,246	1,947	3,276	2,470	76.0	30	Mar 15, 2024	J-GAAP
Jan, 2025	18,905	5,256	6,583	4,961	152.7	35	Mar 14, 2025	J-GAAP
Jan, 2026 Guidance	23,000	5,500	6,530	4,800	147.7	35	Aug 29, 2025	J-GAAP
YoY	+21.7%	+4.6%	-0.8%	-3.2%	-3.3%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Jan, 2021	Mar 13, 2020	9,150	2,370	3,770	2,940	14.5	J-GAAP
	Nov 30, 2020	9,800	2,650	4,300	3,340	17	J-GAAP
Results	Mar 15, 2021	9,801	2,691	4,323	3,377	17	J-GAAP
Jan, 2022	Mar 15, 2021	Available in future release
	Aug 31, 2021
Results	Mar 15, 2022
Jan, 2023	Mar 15, 2022
	Aug 31, 2022
Results	Mar 15, 2023
Jan, 2024	Mar 15, 2023
	Aug 31, 2023
Results	Mar 15, 2024
Jan, 2025	Mar 15, 2024
	Aug 30, 2024
	Feb 14, 2025
Results	Mar 14, 2025
Jan, 2026	Mar 14, 2025	26,000	6,050	6,900	5,000	35	J-GAAP
	Aug 29, 2025	23,000	5,500	6,530	4,800	35	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Jan, 2003	1,816	－	Available in future release
Jan, 2004	1,789	-1.5
Jan, 2005	1,858	+3.9
Jan, 2006	2,089	+12.4
Jan, 2007	2,701	+29.3
Jan, 2008	3,601	+33.3
Jan, 2009	3,244	-9.9
Jan, 2010	2,397	-26.1
Jan, 2011	3,192	+33.2
Jan, 2012	4,015	+25.8
Jan, 2013	3,217	-19.9
Jan, 2014	3,361	+4.5
Jan, 2015	4,103	+22.1
Jan, 2016	4,956	+20.8
Jan, 2017	5,469	+10.4
Jan, 2018	6,445	+17.8
Jan, 2019	7,792	+20.9
Jan, 2020	8,267	+6.1
Jan, 2021	9,801	+18.6
Jan, 2022	11,574	+18.1
Jan, 2023	13,803	+19.3
Jan, 2024	11,246	-18.5
Jan, 2025	18,905	+68.1
Jan, 2026 Guidance	23,000	+21.7	5,500	+4.6	6,530	-0.8	147.7	-3.3

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Jan, 2024	11,246	1,947	17.3	9.24	7.72	0.35	76.0
Jan, 2025	18,905	5,256	27.8	16.77	14.42	0.55	152.7
Jan, 2026 Guidance	23,000	5,500	23.9	13.91	11.38	0.55	147.7

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	18,905	5,256	6,583	4,961	152.7
Fiscal Year	Jan, 2025	Jan, 2025	Jan, 2025	Jan, 2025	Jan, 2025

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Aug - Jan, 2022	7,255	1,593	2,678	2,129	65.5	30	Mar 15, 2023	J-GAAP
Aug - Jan, 2023	5,624	847	1,370	1,017	31.3	30	Mar 15, 2024	J-GAAP
Aug - Jan, 2024	10,931	3,317	3,903	2,930	90.2	35	Mar 14, 2025	J-GAAP
Aug - Jan, 2025 Guidance	10,625	2,323	2,730	2,024	62.3	35	Aug 29, 2025	J-GAAP
YoY	-2.8%	-30.0%	-30.1%	-30.9%	-30.9%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Jan, 2023	3,504	4,835	6,392	-1,557	-1,703	11,137	34.68	J-GAAP
Jan, 2024	1,947	1,191	2,972	-1,781	-1,858	10,497	32.94	J-GAAP
Jan, 2025	5,256	559	3,675	-3,116	-1,620	9,439	25.55	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Feb - Oct, 2023	8,215	1,366	2,439	1,848	56.9	74.5	Nov 30, 2023	J-GAAP
Feb - Oct, 2024	13,105	3,502	4,351	3,226	99.3	66.1	Nov 29, 2024	J-GAAP
Feb - Oct, 2025	18,010	4,561	5,458	4,021	123.8	83.6	Nov 28, 2025	J-GAAP
YoY	+37.4%	+30.2%	+25.4%	+24.6%	+24.6%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Nov - Jan, 2023	3,031	581	837	622	19.2	19.2	Mar 15, 2024	J-GAAP
Feb - Apr, 2024	3,274	664	1,068	812	25.0	20.3	May 31, 2024	J-GAAP
May - Jul, 2024	4,700	1,275	1,612	1,219	37.5	27.1	Aug 30, 2024	J-GAAP
Aug - Oct, 2024	5,131	1,563	1,671	1,195	36.8	30.5	Nov 29, 2024	J-GAAP
Nov - Jan, 2024	5,800	1,754	2,232	1,735	53.4	30.2	Mar 14, 2025	J-GAAP
Feb - Apr, 2025	6,569	1,712	1,640	1,207	37.2	26.1	May 30, 2025	J-GAAP
May - Jul, 2025	5,806	1,465	2,160	1,569	48.3	25.2	Aug 29, 2025	J-GAAP
Aug - Oct, 2025	5,635	1,384	1,658	1,245	38.3	24.6	Nov 28, 2025	J-GAAP
YoY	+9.8%	-11.5%	-0.8%	+4.2%	+4.2%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Nov - Jan, 2020	2,462	+14.4	Available in future release
Feb - Apr, 2021	2,594	+13.4
May - Jul, 2021	2,773	+9.8
Aug - Oct, 2021	3,160	+25.0
Nov - Jan, 2021	3,047	+23.8
Feb - Apr, 2022	3,119	+20.2
May - Jul, 2022	3,429	+23.7
Aug - Oct, 2022	3,591	+13.6
Nov - Jan, 2022	3,664	+20.2
Feb - Apr, 2023	3,228	+3.5
May - Jul, 2023	2,394	-30.2
Aug - Oct, 2023	2,593	-27.8
Nov - Jan, 2023	3,031	-17.3
Feb - Apr, 2024	3,274	+1.4
May - Jul, 2024	4,700	+96.3
Aug - Oct, 2024	5,131	+97.9
Nov - Jan, 2024	5,800	+91.4
Feb - Apr, 2025	6,569	+100.6
May - Jul, 2025	5,806	+23.5
Aug - Oct, 2025	5,635	+9.8	1,384	-11.5	1,658	-0.8	38.3	+4.1

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	6,569	1,754	2,232	1,735	53.4
Fiscal Year	Apr, 2025	Jan, 2024	Jan, 2024	Jan, 2024	Jan, 2024

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Jan, 2023	796.26	80.6	32,115	25,876	18,809	0.13	Mar 15, 2023	J-GAAP
Jan, 2024	848.40	86.5	31,864	27,570	20,304	0.09	Mar 15, 2024	J-GAAP
Jan, 2025	972.02	85.5	36,944	31,587	24,291	0.04	Mar 14, 2025	J-GAAP
Feb - Oct, 2025	ー	81.8	42,191	34,519	27,176	0.11	Nov 28, 2025	J-GAAP

Tri Chemical Laboratories Inc.(4369) Financial Results